1. Home
  2. AIMD vs ATPC Comparison

AIMD vs ATPC Comparison

Compare AIMD & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • ATPC
  • Stock Information
  • Founded
  • AIMD 1984
  • ATPC 2016
  • Country
  • AIMD United States
  • ATPC Malaysia
  • Employees
  • AIMD N/A
  • ATPC N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • ATPC Medical/Nursing Services
  • Sector
  • AIMD Health Care
  • ATPC Health Care
  • Exchange
  • AIMD Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • AIMD 11.9M
  • ATPC 68.0M
  • IPO Year
  • AIMD N/A
  • ATPC N/A
  • Fundamental
  • Price
  • AIMD $2.94
  • ATPC $1.47
  • Analyst Decision
  • AIMD
  • ATPC
  • Analyst Count
  • AIMD 0
  • ATPC 0
  • Target Price
  • AIMD N/A
  • ATPC N/A
  • AVG Volume (30 Days)
  • AIMD 72.7K
  • ATPC 55.8K
  • Earning Date
  • AIMD 08-04-2025
  • ATPC 08-13-2025
  • Dividend Yield
  • AIMD N/A
  • ATPC N/A
  • EPS Growth
  • AIMD N/A
  • ATPC N/A
  • EPS
  • AIMD N/A
  • ATPC N/A
  • Revenue
  • AIMD $106,207.00
  • ATPC $1,293,141.00
  • Revenue This Year
  • AIMD N/A
  • ATPC N/A
  • Revenue Next Year
  • AIMD N/A
  • ATPC N/A
  • P/E Ratio
  • AIMD N/A
  • ATPC N/A
  • Revenue Growth
  • AIMD 13.38
  • ATPC N/A
  • 52 Week Low
  • AIMD $2.00
  • ATPC $0.90
  • 52 Week High
  • AIMD $5.00
  • ATPC $6.80
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 50.61
  • ATPC 45.37
  • Support Level
  • AIMD $3.07
  • ATPC $1.37
  • Resistance Level
  • AIMD $3.34
  • ATPC $1.47
  • Average True Range (ATR)
  • AIMD 0.24
  • ATPC 0.09
  • MACD
  • AIMD 0.04
  • ATPC 0.02
  • Stochastic Oscillator
  • AIMD 60.37
  • ATPC 47.48

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

Share on Social Networks: